O
SRRK icon

OrbiMed’s Scholar Rock SRRK Stock Holding History

OrbiMed’s Portfolio SRRK Stock Details SRRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-151,800
Closed -$4.88M – 116
2025
Q1 		$4.88M Hold
151,800
– – 0.12% 78
2024
Q4 		$6.56M Sell
151,800
-590,500
-80% -$19.2M 0.14% 79
2024
Q3 		$5.95M Sell
742,300
-332,082
-31% -$2.92M 0.11% 93
2024
Q2 		$8.95M Sell
1,074,382
-2,500,250
-70% -$30.6M 0.18% 78
2024
Q1 		$63.5M Sell
3,574,632
-670,368
-16% -$10.6M 1.16% 28
2023
Q4 		$79.8M Buy
4,245,000
+2,211,211
+109% +$27.5M 1.59% 20
2023
Q3 		$14.4M Buy
2,033,789
+1,298,144
+176% +$8.72M 0.31% 69
2023
Q2 		$5.55M Buy
735,645
+220,645
+43% +$1.67M 0.1% 100
2023
Q1 		$4.12M Sell
515,000
-364,003
-41% -$3.69M 0.08% 106
2022
Q4 		$7.95M Buy
879,003
+211,060
+32% +$1.69M 0.15% 79
2022
Q3 		$4.63K Sell
667,943
-408,597
-38% -$3.4M 0.09% 107
2022
Q2 		$5.91K Buy
+1,076,540
New +$7.73M 0.11% 106

Other funds holding SRRK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed's SRRK Position: Q2 2025 in Review

OrbiMed sold out of Scholar Rock (SRRK) in Q2 2025, closing a stake of 151,800 shares — an estimated $4.88M sold.

OrbiMed first reported a position in SRRK in Q2 2022 and held it in 12 quarters. The position peaked at $79.8M in Q4 2023. 235 funds tracked by Wall St. Rank hold SRRK as of Q2 2025.

  • OrbiMed reported no remaining Scholar Rock position as of Q2 2025 after selling out during the quarter.
  • OrbiMed sold 151,800 Scholar Rock shares in Q2 2025, an estimated $4.88M.
  • OrbiMed first reported a position in Scholar Rock in Q2 2022 and held it in 12 quarters.
  • OrbiMed's Scholar Rock position peaked at $79.8M in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Scholar Rock as of Q2 2025.

Based on OrbiMed's 13F filing for Q2 2025, filed 14 Aug 2025.